Michelle D. Holmes

Michelle D. Holmes

Auto-generated profile, based on publicly available information

Michelle D. Holmes

Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, and Harvard Medical School , Boston, MA 02115

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2005 in JAMA
Verified
Journal Article
Closed access
PDF file
MHMichelle D. Holmes
Michelle D. Holmes
WCWendy Y. Chen
Wendy Y. Chen
DFDiane Feskanich
Diane Feskanich
CKCandyce H. Kroenke
Candyce H. Kroenke
GCGraham A Colditz
Graham A Colditz
Research from JAMA — Physical Activity and Survival After Breast Cancer Diagnosis — ContextPhysical activity has been shown to decrease the incidence of breast cancer, but the effect on recurrence or survival after a breast cancer diagnosis is not known.ObjectiveTo determine whether physical activity among women with breast cancer decreases their risk of death from breast cancer compared with more sedentary women.Design, Setting, and ParticipantsProspective observational study based on responses from 2987 female registered nurses in the Nurses’ Health Study who were diagnosed with stage I, II, or III breast cancer between 1984 and 1998 and who were followed up until death or June 2002, whichever came first.Main Outcome MeasureBreast cancer mortality risk according to physical activity category (<3, 3-8.9, 9-14.9, 15-23.9, or ≥24 metabolic equivalent task [MET] hours per week).ResultsCompared with women who engaged in less than 3 MET-hours per week of physical activity, the adjusted relative risk (RR) of death from breast cancer was 0.80 (95% confidence interval [CI], 0.60-1.06) for 3 to 8.9 MET-hours per week; 0.50 (95% CI, 0.31-0.82) for 9 to 14.9 MET-hours per week; 0.56 (95% CI, 0.38-0.84) for 15 to 23.9 MET-hours per week; and 0.60 (95% CI, 0.40-0.89) for 24 or more MET-hours per week (P for trend = .004). Three MET-hours is equivalent to walking at average pace of 2 to 2.9 mph for 1 hour. The benefit of physical activity was particularly apparent among women with hormone-responsive tumors. The RR of breast cancer death for women with hormone-responsive tumors who engaged in 9 or more MET-hours per week of activity compared with women with hormone-responsive tumors who engaged in less than 9 MET-hours per week was 0.50 (95% CI, 0.34-0.74). Compared with women who engaged in less than 3 MET-hours per week of activity, the absolute unadjusted mortality risk reduction was 6% at 10 years for women who engaged in 9 or more MET-hours per week.ConclusionsPhysical activity after a breast cancer diagnosis may reduce the risk of death from this disease. The greatest benefit occurred in women who performed the equivalent of walking 3 to 5 hours per week at an average pace, with little evidence of a correlation between increased benefit and greater energy expenditure. Women with breast cancer who follow US physical activity recommendations may improve their survival.

20 March 2010 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
MHMichelle D. Holmes
Michelle D. Holmes
WCWendy Y. Chen
Wendy Y. Chen
LLLisa Li
Lisa Li
EHEllen Hertzmark
Ellen Hertzmark
DSDonna Spiegelman
Donna Spiegelman
SHSusan E. Hankinson
Susan E. Hankinson
Purpose: Animal and in vitro studies suggest that aspirin may inhibit breast cancer metastasis. We studied whether aspirin use among women with breast cancer decreased their risk of death from breast cancer. Methods: This was a prospective observational study based on responses from 4,164 female registered nurses in the Nurses' Health Study who were diagnosed with stages I, II, or III breast cancer between 1976 and 2002 and were observed until death or June 2006, whichever came first. The main outcome was breast cancer mortality risk according to number of days per week of aspirin use (0, 1, 2 to 5, or 6 to 7 days) first assessed at least 12 months after diagnosis and updated. Results: There were 341 breast cancer deaths. Aspirin use was associated with a decreased risk of breast cancer death. The adjusted relative risks (RRs) for 1, 2 to 5, and 6 to 7 days of aspirin use per week compared with no use were 1.07 (95% CI, 0.70 to 1.63), 0.29 (95% CI, 0.16 to 0.52), and 0.36 (95% CI, 0.24 to 0.54), respectively (test for linear trend, P < .001). This association did not differ appreciably by stage, menopausal status, body mass index, or estrogen receptor status. Results were similar for distant recurrence. The adjusted RRs were 0.91 (95% CI, 0.62 to 1.33), 0.40 (95% CI, 0.24 to 0.65), and 0.57 (95% CI, 0.39 to 0.82; test for trend, P = .03) for 1, 2 to 5, and 6 to 7 days of aspirin use, respectively. Conclusion: Among women living at least 1 year after a breast cancer diagnosis, aspirin use was associated with a decreased risk of distant recurrence and breast cancer death.

5 December 2015 in BMC Public Health
Verified
Journal Article
Open access
PDF file
DGDavid Guwatudde
David Guwatudde
JMJoan Mutyoba
Joan Mutyoba
RKRobert Kalyesubula
Robert Kalyesubula
CLCarien Laurence
Carien Laurence
CAClement Adebamowo
Clement Adebamowo
SDShona Dalal
Shona Dalal
Hypertension, the leading single cause of morbidity and mortality worldwide, is a growing public health problem in sub-Saharan Africa (SSA). Few studies have estimated and compared the burden of hypertension across different SSA populations. We conducted a cross-sectional analysis of blood pressure data collected through a cohort study in four SSA countries, to estimate the prevalence of pre-hypertension, the prevalence of hypertension, and to identify the factors associated with hypertension. Participants were from five different population groups defined by occupation and degree of urbanization, including rural and peri-urban residents in Uganda, school teachers in South Africa and Tanzania, and nurses in Nigeria. We used a standardized questionnaire to collect data on demographic and behavioral characteristics, injuries, and history of diagnoses of chronic diseases and mental health. We also made physical measurements (weight, height and blood pressure), as well as biochemical measurements; which followed standardized protocols across the country sites. Modified Poison regression modelling was used to estimate prevalence ratios (PR) as measures of association between potential risk factors and hypertension. The overall age-standardized prevalence of hypertension among the 1216 participants was 25.9 %. Prevalence was highest among nurses with an age-standardized prevalence (ASP) of 25.8 %, followed by school teachers (ASP = 23.2 %), peri-urban residents (ASP = 20.5 %) and lowest among rural residents (ASP = 8.7 %). Only 50.0 % of participants with hypertension were aware of their raised blood pressure. The overall age-standardized prevalence of pre-hypertension was 21.0 %. Factors found to be associated with hypertension were: population group, older age, higher body mass index, higher fasting plasma glucose level, lower level of education, and tobacco use. The prevalence of hypertension and pre-hypertension are high, and differ by population group defined by occupation and degree of urbanization. Only half of the populations with hypertension are aware of their hypertension, indicating a high burden of undiagnosed and un-controlled high blood pressure in these populations.

1 September 1999 in Cancer
Verified
Journal Article
Open access
PDF file
MHMichelle D. Holmes
Michelle D. Holmes
MSMeir J. Stampfer
Meir J. Stampfer
GCGraham A Colditz
Graham A Colditz
BRBernard Rosner
Bernard Rosner
DHDavid J. Hunter
David J. Hunter
WWWalter C. Willett
Walter C. Willett
BACKGROUND Little is known regarding how specific dietary factors affect the survival of women with breast carcinoma. METHODS Female registered nurses were followed with biennial questionnaires in a prospective cohort with 18 years of follow‐up. Participants were women with breast carcinoma (n = 1982) diagnosed between 1976–1990 who completed a food frequency questionnaire after diagnosis. The main outcome measure was time to death from any cause. Analysis was made by multivariate Cox proportional hazards models. RESULTS In multivariate analyses of diet after diagnosis, no apparent association was found between fat intake and mortality. The relative risk (and 95% confidence interval) of mortality comparing the highest with the lowest quintile of protein intake was 0.65 (0.47–0.88). There was no association between red meat and mortality. These associations were similar in analyses with breast carcinoma death as the outcome. CONCLUSIONS No survival advantage was found for a low fat diet after a diagnosis of breast carcinoma. However, increased survival was observed among women eating more protein, but not red meat. The findings suggest that differences in diet may affect survival after a diagnosis of breast carcinoma and should be examined in greater detail. [See also editorial counterpoint on pages 751–3 and reply to counterpoint on pages 754–5, this issue.] Cancer 1999;86:826–35. © 1999 American Cancer Society.

20 December 2005 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
CKCandyce H. Kroenke
Candyce H. Kroenke
TFTeresa T. Fung
Teresa T. Fung
FHFrank B. Hu
Frank B. Hu
MHMichelle D. Holmes
Michelle D. Holmes
Purpose: There is little prior study of major dietary patterns and breast cancer survival. Methods: Patients included 2,619 Nurses' Health Study participants who were diagnosed with invasive breast cancer between 1982 and 1998 and completed a dietary questionnaire more than 1 year after diagnosis. Participants were followed through 2002 (median = 9 years). During follow-up, 414 patients died of any cause, 242 patients died of breast cancer, and 172 patients died from causes other than breast cancer. Women with in situ or metastatic disease at diagnosis were excluded. We used Cox proportional hazards models to evaluate prospective associations of prudent and Western dietary patterns assessed both before and after diagnosis with time to event after diagnosis. Results: In multivariate-adjusted analyses assessed after diagnosis, the Western and prudent dietary patterns were unrelated to all-cause or breast cancer mortality. However, compared with women with the lowest intake of the prudent dietary pattern, the relative risks (and 95% CIs) of death from causes other than breast cancer were 0.85 (95% CI, 0.53 to 1.35), 0.74 (95% CI, 0.45 to 1.21), 0.70 (95% CI, 0.42 to 1.17), and 0.54 (95% CI, 0.31 to 0.95; P = .03, from lowest to highest quintile of intake). In contrast, the Western dietary pattern was positively associated with this outcome (P = .04). Results for the assessment of dietary patterns before diagnosis were similar, except the prudent dietary pattern was unrelated to mortality. Conclusion: A higher intake of the prudent pattern and a lower intake of the Western pattern may protect against mortality from causes unrelated to breast cancer.

1 February 2005 in Cancer Causes & Control
Verified
Journal Article
Closed access
PDF file
JBJudyAnn Bigby
JudyAnn Bigby
MHMichelle D. Holmes
Michelle D. Holmes